These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1354027)

  • 1. Can brain region-selective dopamine (DA) receptor blockers preferentially act on schizophrenia subtypes?
    Bischoff S; Bruinink A; Gunst F; Krauss J; Schaub M; Vassout A; Maitre L
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():23A-24A. PubMed ID: 1354027
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of D1 and D2 dopamine antagonists on heroin-trained drug discrimination.
    Corrigall WA; Coen KM
    NIDA Res Monogr; 1989; 95():499. PubMed ID: 2577048
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH
    Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O; Parkinson D; Nielsen M
    Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo.
    Andersen PH; Nielsen EB; Grønvald FC; Braestrup C
    Eur J Pharmacol; 1986 Jan; 120(1):143-4. PubMed ID: 2868903
    [No Abstract]   [Full Text] [Related]  

  • 6. [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.
    Grigoriadis D; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):21-5. PubMed ID: 2869417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
    Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
    Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 106(1):219-20. PubMed ID: 6241567
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of action of anti-psychotic drugs.
    Strange PG
    Biochem Soc Trans; 1999 Feb; 27(2):175-8. PubMed ID: 10093729
    [No Abstract]   [Full Text] [Related]  

  • 10. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study.
    Cagnotto A; Parotti L; Mennini T
    Eur J Pharmacol; 1996 Oct; 313(1-2):63-7. PubMed ID: 8905329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
    Barnett A; Ahn HS; Billard W; Gold EH; Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1986 Sep; 128(3):249-53. PubMed ID: 2878816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment.
    Tsai SJ
    Med Hypotheses; 2004; 63(6):1047-50. PubMed ID: 15504573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine D1 receptor: biochemical and behavioral aspects.
    Andersen PH; Nielsen EB
    Adv Exp Med Biol; 1986; 204():73-91. PubMed ID: 2878580
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia.
    Creese I; Hess EJ
    Clin Neuropharmacol; 1986; 9 Suppl 4():14-6. PubMed ID: 2882838
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of rolipram on in vivo dopamine receptor binding.
    Hosoi R; Ishikawa M; Kobayashi K; Gee A; Yamaguchi M; Inoue O
    J Neural Transm (Vienna); 2002 Sep; 109(9):1139-49. PubMed ID: 12203041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 18. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.
    De Keyser J; Walraevens H; Convents A; Ebinger G; Vauquelin G
    Eur J Pharmacol; 1989 Mar; 162(3):437-45. PubMed ID: 2568263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
    Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
    Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated cocaine administration results in supersensitivity of striatal D-2 dopamine autoreceptors to pergolide.
    Dwoskin LP; Peris J; Yasuda RP; Philpott K; Zahniser NR
    Life Sci; 1988; 42(3):255-62. PubMed ID: 3275855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.